Literature DB >> 20159520

Quality improvement for pancreatic cancer care: is regionalization a feasible and effective mechanism?

Mehul V Raval1, Karl Y Bilimoria, Mark S Talamonti.   

Abstract

Variability exists in the quality of pancreatic cancer care provided in the United States. High-volume centers have been shown to have improved outcomes for pancreatectomy. Regionalization of pancreatic cancer care to high-volume centers has the potential to improve care and outcomes. Practical limitations such as overloading currently available high-volume centers, extending patient travel times, sharing patients within a multipayer health system, and incorporating patient preferences must be addressed for regionalization to become a reality. The benefits and limitations of regionalization of pancreatic cancer care are discussed in this review. To improve the overall quality of pancreatic cancer care at all hospitals in the United States, a combination of referral of patients with pancreatic cancer to high- and moderate-volume hospitals in conjunction with specific quality-improvement efforts at those institutions is proposed.

Entities:  

Mesh:

Year:  2010        PMID: 20159520     DOI: 10.1016/j.soc.2009.11.011

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  6 in total

1.  Hospital Volume and Survival After Hepatocellular Carcinoma Diagnosis.

Authors:  Ali A Mokdad; Hong Zhu; Jorge A Marrero; John C Mansour; Amit G Singal; Adam C Yopp
Journal:  Am J Gastroenterol       Date:  2016-05-10       Impact factor: 10.864

2.  Textbook oncologic outcome in pancreaticoduodenectomy: Do regionalization efforts make sense?

Authors:  Sujay Kulshrestha; Patrick J Sweigert; Celsa Tonelli; Corinne Bunn; Fred A Luchette; Zaid M Abdelsattar; Timothy M Pawlik; Marshall S Baker
Journal:  J Surg Oncol       Date:  2021-10-07       Impact factor: 3.454

Review 3.  Does the Volume-Outcome Association in Pancreas Cancer Surgery Justify Regionalization of Care? A Review of Current Controversies.

Authors:  Alexandra W Acher; Sharon M Weber; Timothy M Pawlik
Journal:  Ann Surg Oncol       Date:  2021-09-14       Impact factor: 5.344

Review 4.  Neoadjuvant therapy for resectable pancreatic cancer.

Authors:  Sheikh Hasibur Rahman; Robin Urquhart; Michele Molinari
Journal:  World J Gastrointest Oncol       Date:  2017-12-15

5.  A Survival Analysis of Gastric or Colorectal Cancer Patients Treated With Surgery: Comparison of Capital and a Non-capital City.

Authors:  Nam-Soo Hong; Kyeong Soo Lee; Sin Kam; Gyu Seog Choi; Oh Kyoung Kwon; Dong Hee Ryu; Sang Won Kim
Journal:  J Prev Med Public Health       Date:  2017-09

6.  Cancer resection rates, socioeconomic deprivation, and geographical access to surgery among urban, suburban, and rural populations across Canada.

Authors:  Blake Byron Walker; Nadine Schuurman; Chuck K Wen; Saad Shakeel; Laura Schneider; Christian Finley
Journal:  PLoS One       Date:  2020-10-14       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.